 |
|
Incidence of Hepatitis A in the United States in the Era of Vaccination
Annemarie Wasley, ScD;
Taraz Samandari, MD, PhD;
Beth P. Bell, MD, MPH
JAMA. 2005;294:194-201.
Context In the United States, hepatitis A is a frequently reported vaccine-preventable disease. Vaccination has been recommended for persons at increased risk since 1996. In 1999, it was recommended that children living in 11 states with the highest incidence of hepatitis A be routinely vaccinated, and that children living in 6 additional states, with incidence above the national average, be considered for routine vaccination.
Objective To assess impact of the current vaccination strategy by evaluating trends in reported cases of hepatitis A since implementation.
Design, Setting, and Cases A longitudinal analysis of characteristics of cases of hepatitis A reported in the United States since 1990 to the National Notifiable Diseases Surveillance System.
Main Outcome Measure Incidence rates of reported cases of hepatitis A. Incidence rates in 2003 were compared with those for the prevaccination baseline period (1990-1997) overall and in the 17 states in which children should be routinely vaccinated or considered for routine vaccination (vaccinating states). Incidence rates in vaccinating states were also compared with those in the remaining states where there is no recommendation for statewide vaccination of children (nonvaccinating states).
Results Between the baseline period (1990-1997) and 2003, overall hepatitis A rates declined 76% to 2.6 per 100 000, significantly lower than previous nadirs in 1983 (9.2/100 000) and 1992 (9.1/100 000). The rate in vaccinating states declined 88% to 2.5 per 100 000 compared with 53% elsewhere (to 2.7/100 000). In 2003, cases from vaccinating states accounted for 33% of the national total vs 65% during the baseline period. Declines were greater among children aged 2 to 18 years (87%) than among persons older than age 18 years (69%); the proportion of cases in children dropped from 35% to 19%. Since 2001, rates in adults have been higher than among children, with the highest rates now among men aged 25 through 39 years.
Conclusions Following implementation of routine hepatitis A vaccination of children, hepatitis A rates have declined to historic lows, accompanied by substantial changes in the epidemiologic profile. Greater decreases in the age groups and regions where routine vaccination of children is recommended likely reflect the results of implementation of this novel vaccination strategy. Continued monitoring is needed to verify that implementation continues to proceed and that low rates are sustained.
Author Affiliations: Division of Viral Hepatitis (Drs Wasley, Samandari, and Bell) and Epidemic Intelligence Service, Epidemiology Program Office (Dr Samandari), Centers for Disease Control and Prevention, Atlanta, Ga. Dr Samandari is now with BOTUSA, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Republic of Botswana, Africa.
RELATED ARTICLES
Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers
Ron Dagan, Alex Leventhal, Emilia Anis, Paul Slater, Yaffa Ashur, and Daniel Shouval
JAMA. 2005;294(2):202-210.
ABSTRACT
| FULL TEXT
Effect of Hepatitis A Vaccination Programs
Pierre Van Damme and Koen Van Herck
JAMA. 2005;294(2):246-248.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Index of Suspicion in the Nursery
Alapati et al.
NeoReviews 2008;9:e170-e173.
FULL TEXT
Hepatitis A Vaccine versus Immune Globulin for Postexposure Prophylaxis
Victor et al.
NEJM 2007;357:1685-1694.
ABSTRACT
| FULL TEXT
Hepatitis A Vaccine Recommendations
Committee on Infectious Diseases
Pediatrics 2007;120:189-199.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States
Rein et al.
Pediatrics 2007;119:e12-e21.
ABSTRACT
| FULL TEXT
Incorporating Vaccine-Preventable Disease Surveillance Into the National Health Information Network: Leveraging Children's Hospitals
Fine et al.
Pediatrics 2006;118:1431-1438.
ABSTRACT
| FULL TEXT
Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly With Diphtheria-Tetanus-Acellular Pertussis and Haemophilus influenzae Type B Vaccines to Children Less Than 2 Years of Age
Nolan et al.
Pediatrics 2006;118:e602-e609.
ABSTRACT
| FULL TEXT
Hepatitis A in the Era of Vaccination
Wasley et al.
Epidemiol Rev 2006;28:101-111.
ABSTRACT
| FULL TEXT
Should all children be immunised against hepatitis A?
Temte
BMJ 2006;332:715-718.
FULL TEXT
Declining Incidence of Hepatitis A
Chodick and Shalev
JAMA 2006;295:282-282.
FULL TEXT
Diagnosis of Hepatitis A Virus Infection: a Molecular Approach
Nainan et al.
Clin. Microbiol. Rev. 2006;19:63-79.
ABSTRACT
| FULL TEXT
Decline of Hepatitis A in the US: Another Vaccine Success Story
Schiff
AAP Grand Rounds 2005;14:37-38.
FULL TEXT
An Outbreak of Hepatitis A Associated with Green Onions
Wheeler et al.
NEJM 2005;353:890-897.
ABSTRACT
| FULL TEXT
Hepatitis A -- The Price of Progress
Di Giammarino and Dienstag
NEJM 2005;353:944-946.
FULL TEXT
Changing Epidemiology of Hepatitis A Following Immunization Programs
JWatch Infect. Diseases 2005;2005:2-2.
FULL TEXT
Epidemiology of Hepatitis A Transformed by Vaccine
JWatch General 2005;2005:1-1.
FULL TEXT
Effect of Hepatitis A Vaccination Programs
Van Damme and Van Herck
JAMA 2005;294:246-248.
FULL TEXT
|
